Document is current
Any future updates will be listed below
-
Authors
Russo, Mariangela
Chen, Mengnuo
Mariella, Elisa http://orcid.org/0000-0002-3612-8116
Peng, Haoning http://orcid.org/0000-0003-1388-3255
Rehman, Sumaiyah K.
Sancho, Elena http://orcid.org/0000-0002-8182-513X
Sogari, Alberto
Toh, Tzen S.
Balaban, Nathalie Q.
Batlle, Eduard http://orcid.org/0000-0003-2422-0326
Bernards, Rene http://orcid.org/0000-0001-8677-3423
Garnett, Mathew J. http://orcid.org/0000-0002-2618-4237
Hangauer, Matthew
Leucci, Eleonora http://orcid.org/0000-0002-2898-748X
Marine, Jean-Christophe http://orcid.org/0000-0003-2433-9837
O’Brien, Catherine A.
Oren, Yaara
Patton, E. Elizabeth http://orcid.org/0000-0002-2570-0834
Robert, Caroline http://orcid.org/0000-0002-9493-0238
Rosenberg, Susan M. http://orcid.org/0000-0003-1444-473X
Shen, Shensi http://orcid.org/0000-0002-5087-8220
Bardelli, Alberto http://orcid.org/0000-0003-1647-5070
- License Information
-
More Information
Article History
Accepted: 29 July 2024
First Online: 2 September 2024
Competing interests
: A.B. reports receipt of grants/research supports from Neophore, AstraZeneca and Boehringer Ingelheim and honoraria/consultation fees from Guardant Health and Inivata. A.B. is a stock shareholder of Neophore and Kither Biotech. A.B. is an advisory boards member for Inivata, Neophore and Roche/Genentech. E.B. provides consultancy services to Roche, and his laboratory has entered into sponsored research agreements and received funding from Merus NL, Incyte and Revolution Medicines. S.S. reports personal fees from Agence nationale de la recherche (France), Krebsliga Schweiz (Switzerland), KWF Kankerbestrijding (The Netherlands) and Shenzhen Medical Academy of Research and Translation (China). M.J.G. has received research grants from AstraZeneca, GlaxoSmithKline and Astex Pharmaceuticals and is a consultant for and holds equity in Mosaic Therapeutics. M.H. is a cofounder and consultant for, and has received research grant funding from, Ferro Therapeutics (BridgeBio). M.R., M.C., E.M., H.P., S.K.R., E.S., A.S., T.S.T., N.Q.B., R.B., E.L., J.-C.M., C.A.O., Y.O., E.E.P., C.R. and S.M.R. declare no competing interests.
